Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
Alpha Tau Medical (NASDAQ: DRTS), developer of the Alpha DaRT® alpha-radiation cancer therapy, announces CFO Raphi Levy's participation in two major healthcare conferences. Levy will attend the Citi 2024 Global Healthcare Conference on December 3rd in Miami, FL, participating in one-on-one meetings from 8:30 AM to 4:30 PM EST. Additionally, he will join the Piper Sandler 36th Annual Healthcare Conference on December 5th in New York, NY, featuring a fireside chat from 10:00-10:25 AM EST along with one-on-one meetings.
Alpha Tau Medical (NASDAQ: DRTS), sviluppatore della terapia oncologica alpha-radiativa Alpha DaRT®, annuncia la partecipazione del CFO Raphi Levy a due importanti conferenze sanitarie. Levy parteciperà alla Citi 2024 Global Healthcare Conference il 3 dicembre a Miami, FL, partecipando a incontri individuali dalle 8:30 alle 16:30 EST. Inoltre, si unirà alla Piper Sandler 36th Annual Healthcare Conference il 5 dicembre a New York, NY, dove parteciperà a una chiacchierata informale dalle 10:00 alle 10:25 EST, oltre a incontri uno a uno.
Alpha Tau Medical (NASDAQ: DRTS), desarrollador de la terapia contra el cáncer de radiación alfa Alpha DaRT®, anuncia la participación del CFO Raphi Levy en dos importantes conferencias de salud. Levy asistirá a la Citi 2024 Global Healthcare Conference el 3 de diciembre en Miami, FL, participando en reuniones individuales de 8:30 AM a 4:30 PM EST. Además, se unirá a la Piper Sandler 36th Annual Healthcare Conference el 5 de diciembre en Nueva York, NY, donde participará en una charla informal de 10:00 a 10:25 AM EST, junto con reuniones uno a uno.
알파 타우 메디컬 (NASDAQ: DRTS)은 알파 방사선 암 치료제 Alpha DaRT®의 개발업체로, CFO 라피 레비(Raphi Levy)의 두 주요 의료 회의 참여를 발표했습니다. 레비는 12월 3일 플로리다주 마이애미에서 열리는 Citi 2024 Global Healthcare Conference에 참석하여 동부 표준시 기준 오전 8시 30분부터 오후 4시 30분까지 1:1 회의에 참여합니다. 추가로, 그는 12월 5일 뉴욕에서 열리는 Piper Sandler 36th Annual Healthcare Conference에서 오전 10시부터 10시 25분까지 진행되는 대담에 참석하고, 1:1 회의에도 참여할 예정입니다.
Alpha Tau Medical (NASDAQ: DRTS), développeur de la thérapie contre le cancer par radiation alpha Alpha DaRT®, annonce la participation de son CFO Raphi Levy à deux grandes conférences de santé. Levy assistera à la Citi 2024 Global Healthcare Conference le 3 décembre à Miami, FL, participant à des réunions individuelles de 8h30 à 16h30 EST. De plus, il se joindra à la Piper Sandler 36th Annual Healthcare Conference le 5 décembre à New York, NY, où il participera à une discussion informelle de 10h00 à 10h25 EST, ainsi qu'à des réunions en tête-à-tête.
Alpha Tau Medical (NASDAQ: DRTS), Entwickler der Alpha-Radiation Krebstherapie Alpha DaRT®, kündigt die Teilnahme von CFO Raphi Levy an zwei wichtigen Gesundheitskonferenzen an. Levy wird am 3. Dezember an der Citi 2024 Global Healthcare Conference in Miami, FL, teilnehmen und von 8:30 bis 16:30 Uhr EST an Einzelgesprächen teilnehmen. Darüber hinaus wird er am 5. Dezember an der Piper Sandler 36th Annual Healthcare Conference in New York, NY teilnehmen, wo er von 10:00 bis 10:25 Uhr EST an einem Kamin-Gespräch teilnehmen wird, zusammen mit Einzelgesprächen.
- None.
- None.
JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will participate in the Citi 2024 Global Healthcare Conference on December 3rd, 2024 and the Piper Sandler 36th Annual Healthcare Conference on December 5th, 2024.
| Event: | Citi 2024 Global Healthcare Conference |
| Format: | 1-on-1 Meetings |
| Date: | December 3, 2024 |
| Time: | 8:30AM – 4:30PM EST |
| Location: | Miami, FL |
| Event: | Piper Sandler 36thAnnual Healthcare Conference |
| Format: | Fireside Chat and 1-on-1 Meetings |
| Date: | December 5, 2024 |
| Time: | 10:00-10:25AM EST |
| Location: | New York, NY |
Please reach out to your Citi and Piper Sandler representatives to schedule 1-on-1 meetings with Mr. Levy.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT ®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.
Investor Relations Contact: IR@alphatau.com
FAQ
When is Alpha Tau Medical (DRTS) participating in the Citi Global Healthcare Conference 2024?
What is Alpha Tau Medical's (DRTS) schedule at the Piper Sandler Healthcare Conference?
Who will represent Alpha Tau Medical (DRTS) at the healthcare conferences in December 2024?
What type of sessions will Alpha Tau Medical (DRTS) participate in at these conferences?
